GlassScriptPhysician profile
Amanda Griffin
NPI 1518386135
$1,325.78
in general payments reported to CMS, 2019-2025
20 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $670 · 2020: $262 · 2023: $86.90 · 2024: $167 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $393.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $301.63 | 2019-2024 | Farxiga |
| Lilly USA, LLC | $166.78 | 2019-2023 | Mounjaro |
| Ars Pharmaceuticals Operations, INC. | $124.96 | 2025 | Neffy |
| Edwards Lifesciences Corporation | $112.26 | 2019 | |
| Novo Nordisk INC | $85.39 | 2019-2024 | Wegovy |
| Merck Sharp & Dohme LLC | $82.18 | 2019-2025 | Gardasil 9, Vaqta, Capvaxive |
| Abbvie INC. | $68.93 | 2023-2024 | |
| Glaxosmithkline, LLC. | $62.02 | 2023-2024 | Shingrix, Arexvy |
| Amarin Pharma, INC. | $54.16 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $43.06 | 2019-2020 | |
| Amgen INC. | $40.30 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $34.34 | 2024 | Xifaxan |
| Neotract INC. | $28.78 | 2019 | |
| Pfizer INC. | $25.42 | 2019-2020 | |
| Abbott Laboratories | $21.19 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $20.46 | 2023 | Cologuard Collection Kit |
| Kowa Pharmaceuticals America, INC. | $14.03 | 2020 | |
| Astellas Pharma US INC | $13.63 | 2019 | |
| Sanofi Pasteur INC. | $13.13 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $13.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Griffin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.